Eye diseases are more common and more likely than many people realize, so routine eye care is essential for all. Exams can tell you more about minute changes in your health and eyesight, and these tests can be the first time early signs of disease are caught. This is important if you are at risk for a condition, including age-related macular degeneration. Here at The Retina Group of Washington, our eye surgeon in Burke can provide you with the comprehensive care you need from diagnosis to treatment.
Age-related macular degeneration is a genetic condition, so it is hereditary. This means that if you have a family medical history of this condition, you are likely to develop it as well. As the name would suggest, this is more likely to occur with age, and seniors over the age of 60 or so are likely to develop symptoms around this time in their lives. People of all ages should have annual eye exams conducted, but people with this condition may need to schedule more frequent exams the older they get. Macular degeneration causes declining eyesight, and it can come in two types: wet and dry. Methods of treatment may vary depending on these factors, and we here at The Retina Group of Washington offer laser photocoagulation and photodynamic therapy. Laser photocoagulation can be used to destroy fragile, leaky blood vessels using a high-energy beam of light that is aimed directly onto the vessels to prevent further loss of vision. Photodynamic therapy slows the rate of vision loss, but does not stop vision loss entirely or restore vision in eyes that are already damaged. Treatment results often are temporary, and you may need to be treated again, but in eyes treated with laser therapy, vision loss may progress despite repeated treatments as well.
If you have age-related macular degeneration, our eye surgeon in Burke is here to track your developing condition and provide you with advice regarding these treatment methods. To learn more about this disease or about laser photocoagulation and photodynamic therapy, call us here at The Retina Group of Washington today.